Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Noro Psikiyatri Arsivi|September 26, 2022
The Socioeconomic and Psychological Impact of the COVID-19 Pandemic on People with Multiple Sclerosis in TurkeyTuncay Gündüz, Cihat Uzunköprü, Serkan Demir, et al.
Multiple Sclerosis and Related Disorders|February 11, 2024
Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR studyAli Özhan Sıvacı, Meral Seferoğlu, Bilge Piri Çınar, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 19, 2025
Treatment Adherence in a Large Cohort of Turkish Multiple Sclerosis PopulationMeral Seferoğlu, Bilge Piri Çınar, Ülgen Yalaz Tekan, et al.
International Journal of Clinical Practice|March 20, 2021
The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from TurkeyCihat Uzunköprü, Melih Tütüncü, Tuncay Gündüz, et al.
Multiple Sclerosis and Related Disorders|May 25, 2022
The effect of cognitive performance on self-management behavior of multiple sclerosis patientsHüsnü Efendi, Aysun Ünal, Aylin Akçalı, et al.
Noro Psikiyatri Arsivi|August 30, 2023
The Effect of Smoking on Inactivated and mRNA Vaccine Responses Applied to Prevent COVİD-19 in Multiple SclerosisSedat Şen, Gökhan Arslan, Melih Tütüncü, et al.
Multiple Sclerosis and Related Disorders|May 29, 2023
mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity-Does it matter?Melih Tütüncü, Serkan Demir, Gökhan Arslan, et al.
Noro Psikiyatri Arsivi|March 13, 2023
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod TreatmentMurat Terzi, Elif Merve Helvacı, Sedat Şen, et al.
Journal of Neuroimmunology|July 22, 2025
Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD)Sedat Şen, Murat Kürtüncü, Serkan Demir, et al.
Scientific Reports|April 5, 2025
Exome sequencing reveals low-frequency and rare variant contributions to multiple sclerosis susceptibility in Turkish familiesFurkan Büyükgöl, Berk Gürdamar, Mehmet Ufuk Aluçlu, et al.
Pageof 3